Neuropsychiatric symptoms of dementia: Consent, quality of life, and dignity

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Passmore, Michael J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGITATION; ANXIETY DISORDER; CAREGIVER; CLINICAL DECISION MAKING; DELIRIUM; DEMENTIA; EXPECTATION; FAMILY COUNSELING; FUNCTIONAL STATUS; HUMAN; HUMAN DIGNITY; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MORBIDITY; MORTALITY; PAIN; PALLIATIVE THERAPY; PATIENT AUTONOMY; PATIENT COUNSELING; PATIENT SAFETY; PRACTICE GUIDELINE; PROGNOSIS; PSYCHOSIS; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW (TOPIC); TERMINAL CARE; ARTICLE; PERSONHOOD; PSYCHOLOGICAL ASPECT; PSYCHOLOGY;

DEMENTIA; HUMANS; PALLIATIVE CARE; PERSONHOOD; PRACTICE GUIDELINES AS TOPIC; QUALITY OF LIFE;

EID: 84880144729     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/230134     Document Type: Review

References (29)

1. Lyketsos C. G., Lopez O., Jones B., Fitzpatrick A. L., Breitner J., Dekosky S., Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. Journal of the American Medical Association 2002 288 12 1475 1483 2-s2.0-0037174346
2. Mitchell S. L., Kiely D. K., Hamel M. B., Dying with advanced dementia in the nursing home. Archives of Internal Medicine 2004 164 3 321 326 2-s2.0-0842348757 10.1001/archinte.164.3.321
3. Mate K. E., Pond C. D., Magin P. J., Diagnosis and disclosure of a memory problem is associated with quality of life in community based older Australians with dementia. International Psychogeriatrics 2012 24 12 1962 1971
4. Hogan D. B., Bailey P., Black S., Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia. Canadian Medical Association Journal 2008 179 8 787 793 10.1503/cmaj.070803
5. Phillips J., Pond C. D., Paterson N. E., Difficulties in disclosing the diagnosis of dementia: a qualitative study in general practice. British Journal of General Practice 2012 62 e546 e553
6. Moore V., Cahill S., Diagnosis and disclosure of dementia-a comparative qualitative study of Irish and Swedish General Practitioners. Aging & Mental Health 2013 17 1 77 84 10.1080/13607863.2012.692763
7. Kai J., Beavan J., Faull C., Challenges of mediated communication, disclosure and patient autonomy in cross-cultural cancer care. British Journal of Cancer 2011 105 7 918 924 2-s2.0-84860407594 10.1038/bjc.2011.318
8. Karnieli-Miller O., Werner P., Aharon-Peretz J., Expectations, experiences, and tensions in the memory clinic: the process of diagnosis disclosure of dementia within a triad. International Psychogeriatrics 2012 24 11 1756 1770 10.1017/S1041610212000841
9. von Kutzleben M., Schmid W., Halek M., Holle B., Bartholomeyczik S., Community-dwelling persons with dementia: what do they need? What do they demand? What do they do? A systematic review on the subjective experiences of persons with dementia. Aging and Mental Health 2012 16 3 378 390 2-s2.0-84859712836 10.1080/13607863.2011.614594
10. Carpenter B. D., Xiong C., Porensky E. K., Lee M. M., Brown P. J., Coats M., Johnson D., Morris J. C., Reaction to a dementia diagnosis in individuals with Alzheimer's disease and mild cognitive impairment. Journal of the American Geriatrics Society 2008 56 3 405 412 2-s2.0-40149087698 10.1111/j.1532-5415. 2007.01600.x
11. Lee L., Weston W. W., Disclosing a diagnosis of dementia: helping learners to break bad news. Canadian Family Physician 2011 57 7 e851 e852 2-s2.0-79960462916
12. Billings J. A., Krakauer E. L., On patient autonomy and physician responsibility in end-of-life care. Archives of Internal Medicine 2011 171 9 849 853 2-s2.0-79955780406 10.1001/archinternmed.2011.180
13. Banerjee S., The use of antipsychotic medication for people with dementia: Time for action. UK Department of Health, 2009, http://www.dh.gov.uk/ prod-consum-dh/groups/dh-digitalassets/documents/digitalasset/dh-108302.pdf
14. Huybrechts K. F., Rothman K. J., Silliman R. A., Brookhart M. A., Schneeweiss S., Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. Canadian Medical Association Journal 2011 183 7 E411 E419 2-s2.0-79955125975 10.1503/cmaj.101406
15. Ballard C., Hanney M. L., Theodoulou M., Douglas S., McShane R., Kossakowski K., Gill R., Juszczak E., Yu L., Jacoby R., The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. The Lancet Neurology 2009 8 2 151 157 2-s2.0-58649100881 10.1016/S1474-4422(08)70295-3
16. Schneider L. S., Tariot P. N., Dagerman K. S., Davis S. M., Hsiao J. K., Ismail M. S., Lebowitz B. D., Lyketsos C. G., Ryan J. M., Stroup T. S., Sultzer D. L., Weintraub D., Lieberman J. A., Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine 2006 355 15 1525 1538 2-s2.0-33749618085 10.1056/NEJMoa061240
17. Naarding P., Van Grevenstein M., Beekman A. T. F., Benefit-risk analysis for the clinician: "primum non nocere" revisited-the case for antipsychotics in the treatment of behavioural disturbances in dementia. International Journal of Geriatric Psychiatry 2010 25 5 437 440 2-s2.0-77950840270 10.1002/gps.2357
18. van de Ven-Vakhteeva J., Bor H., Wetzels R. B., The impact of antipsychotics and neuropsychiatric symptoms on the quality of life of people with dementia living in nursing homes. International Journal of Geriatric Psychiatry 2013 28 5 530 538 10.1002/gps.3858
19. Ballard C., Lana M. M., Theodoulou M., Douglas S., McShane R., Jacoby R., Kossakowski K., Yu L., Juszczak E., A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (The DART-AD Trial). PLoS Medicine 2008 5 4 587 599 e76 10.1371/journal.pmed.0050076
20. Devanand D. P., Pelton G. H., Cunqueiro K., Sackeim H. A., Marder K., A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease. International Journal of Geriatric Psychiatry 2011 26 9 937 943 2-s2.0-79951816345 10.1002/gps.2630
21. Devanand D. P., Mintzer J., Schultz S. K., Relapse risk after discontinuation of risperidone in Alzheimer's disease. The New England Journal of Medicine 2012 367 1497 1507 10.1056/NEJMoa1114058
22. Husebo B. S., Ballard C., Sandvik R., Nilsen O. B., Aarsland D., Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. British Medical Journal 2011 343 d4065 2-s2.0-84857404382
23. Simard J., Volicer L., Effects of namaste care on residents who do not benefit from usual activities. American Journal of Alzheimer's Disease and other Dementias 2010 25 1 46 50 2-s2.0-77749283586 10.1177/1533317509333258
24. Providence Health Care-Palliative Care Service Team. Vancouver BC. 2011
25. Parsons C., Hughes C. M., Passmore A. P., Lapane K. L., Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying? Drugs and Aging 2010 27 6 435 449 2-s2.0-77953275286 10.2165/11536760-000000000-00000
26. Volicer L., Goals of care in advanced dementia: quality of life, dignity and comfort. Journal of Nutrition, Health and Aging 2007 11 6 481 2-s2.0-37049004180
27. Volicer L., Bloom-Charette L., Enhancing the Quality of Life in Advanced Dementia 1999 Philadelphia, Pa, USA Taylor & Francis
28. Fook J., Kellehear A., Using critical reflection to support health promotion goals in palliative care. Journal of Palliative Care 2010 26 4 295 302 2-s2.0-78651066523
29. MyVoice-Advance care planning guide. BC Ministry of Health. 2012, http://www.health.gov.bc.ca/library/publications/year/2013/MyVoice- AdvanceCarePlanningGuide.pdf